Pregled bibliografske jedinice broj: 1060579
Melasma - Review of Current Treatment Modalities and Efficacy Assessment of a New Resorcinol-Based Topical Formulation
Melasma - Review of Current Treatment Modalities and Efficacy Assessment of a New Resorcinol-Based Topical Formulation // Journal of Clinical and Cosmetic Dermatology, 1 (2017), 3; 1-4 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1060579 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Melasma - Review of Current Treatment
Modalities and Efficacy Assessment of a New
Resorcinol-Based Topical Formulation
Autori
Kaliterna, D ; Žužul, K ; Kovačević, I
Izvornik
Journal of Clinical and Cosmetic Dermatology (2576-2826) 1
(2017), 3;
1-4
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Melasma ; Resorcinol ; Pigmentary Disorders ; Melasma Treatment
Sažetak
Melasma is one of the most common pigmentary disorders characterized by symmetrical pigmented macules on the face. It most commonly affects women of reproductive age with darker complexions, and has a considerable impact on quality of life. The pathogenesis of melasma is complex and involves various risk factors such as genetic predisposition, UV exposure, darker phototype and hormonal influence. Because of its chronic and relapsing course, as well as the fact that despite numerous treatment modalities available, no single treatment option has proven to be efficient for all patients with melasma, the treatment still remains a challenge. This paper provides a review of the current literature on melasma treatment and presents the results of a study assessing a new promising resorcinol-based topical formulation with better efficacy and safety profile than other currently available treatment options for melasma.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti